131 related articles for article (PubMed ID: 31751529)
21. Immune reconstitution inflammatory syndrome of Kaposi's sarcoma in an HIV-infected patient.
Lu CL; Chang SY; Tseng YT; Wu BR; Liu WC; Hsieh CY; Wu PY; Sun HY; Hung CC
J Microbiol Immunol Infect; 2013 Aug; 46(4):309-12. PubMed ID: 22503798
[TBL] [Abstract][Full Text] [Related]
22. AIDS presenting with cutaneous Kaposi's sarcoma and bacillary angiomatosis in the bone marrow mimicking Kaposi's sarcoma.
Rosales CM; McLaughlin MD; Sata T; Katano H; Veno PA; de Las Casas LE; Miranda RN
AIDS Patient Care STDS; 2002 Dec; 16(12):573-7. PubMed ID: 12542930
[TBL] [Abstract][Full Text] [Related]
23. Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi's sarcoma.
Martin-Carbonero L; Barrios A; Saballs P; Sirera G; Santos J; Palacios R; Valencia ME; Alegre M; Podzamczer D; González-Lahoz J;
AIDS; 2004 Aug; 18(12):1737-40. PubMed ID: 15280789
[TBL] [Abstract][Full Text] [Related]
24. Kaposi's sarcoma in a HIV-positive patient: an exuberant and widespread case report in the Amazon.
Pires CAA; Monteiro JCMS; Rego RM; Lodi VJC
Rev Inst Med Trop Sao Paulo; 2020; 62():e2. PubMed ID: 31967210
[TBL] [Abstract][Full Text] [Related]
25. Kaposi's sarcoma in the era of HAART-an update on mechanisms, diagnostics and treatment.
Dittmer DP; Vahrson W; Staudt M; Hilscher C; Fakhari FD
AIDS Rev; 2005; 7(1):56-61. PubMed ID: 15875661
[TBL] [Abstract][Full Text] [Related]
26. HIV-associated Kaposi's sarcoma.
Jessop S
Dermatol Clin; 2006 Oct; 24(4):509-20, vii. PubMed ID: 17010779
[TBL] [Abstract][Full Text] [Related]
27. [Kaposi sarcoma in HIV patients: Response to antiretroviral treatment and chemotherapy].
Lasso M; Pérez J; Noriega L; Malebrán A; Espinoza S
Rev Med Chil; 2003 May; 131(5):483-90. PubMed ID: 12879808
[TBL] [Abstract][Full Text] [Related]
28. Kaposi's sarcoma-like angiosarcomas may reflect a common lymphatic endothelium differentiation pattern as Kaposi's sarcoma in association with chronic lymphedema.
Smith KJ; Skelton H
Int J Dermatol; 2006 May; 45(5):623-6. PubMed ID: 16700808
[No Abstract] [Full Text] [Related]
29. Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials.
Cahn P; Madero JS; Arribas JR; Antinori A; Ortiz R; Clarke AE; Hung CC; Rockstroh JK; Girard PM; Sievers J; Man C; Currie A; Underwood M; Tenorio AR; Pappa K; Wynne B; Fettiplace A; Gartland M; Aboud M; Smith K;
Lancet; 2019 Jan; 393(10167):143-155. PubMed ID: 30420123
[TBL] [Abstract][Full Text] [Related]
30. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
31. Immune reconstitution inflammatory syndrome Kaposi sarcoma in the liver manifesting as acute obstructive hepatitis: another potential role for montelukast?
Read PJ; Lucas S; Morris S; Kulasegaram R
Int J STD AIDS; 2013 Feb; 24(2):156-8. PubMed ID: 24400347
[TBL] [Abstract][Full Text] [Related]
32. Virological suppression after use of crushed tenofovir-emtricitabine and dolutegravir tablets in a patient with HIV infection.
Buscemi L
Am J Health Syst Pharm; 2016 Aug; 73(15):1125-6. PubMed ID: 27440618
[No Abstract] [Full Text] [Related]
33. Physiotherapy management of patients with HIV-associated Kaposi's sarcoma.
Harris-Love MO; Shrader JA
Physiother Res Int; 2004; 9(4):174-81. PubMed ID: 15790255
[TBL] [Abstract][Full Text] [Related]
34. Single-tablet antiretroviral treatment (once daily).
Andany N; Gold WL
CMAJ; 2016 Sep; 188(13):971. PubMed ID: 27221274
[No Abstract] [Full Text] [Related]
35. Interferon therapy for Kaposi sarcoma associated with acquired immunodeficiency syndrome: still a valid treatment option?
Rouanet I; Lechiche C; Doncesco R; Mauboussin JM; Sotto A
AIDS Patient Care STDS; 2013 Oct; 27(10):537-8. PubMed ID: 24050760
[No Abstract] [Full Text] [Related]
36. Peculiar type of KS emerges in healthier individuals.
Proj Inf Perspect; 2008 Dec; (47):13-4. PubMed ID: 19230234
[No Abstract] [Full Text] [Related]
37. Clinical outcomes of HIV-infected patients with Kaposi's sarcoma receiving nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy in Uganda.
Asiimwe F; Moore D; Were W; Nakityo R; Campbell J; Barasa A; Mermin J; Kaharuza F
HIV Med; 2012 Mar; 13(3):166-71. PubMed ID: 22112164
[TBL] [Abstract][Full Text] [Related]
38. Kaposi's sarcoma in an HIV-positive person successfully treated with paclitaxel.
Dongre A; Montaldo C
Indian J Dermatol Venereol Leprol; 2009; 75(3):290-2. PubMed ID: 19439884
[TBL] [Abstract][Full Text] [Related]
39. [Diagnosis and treatment of HIV-related Kaposi's sarcoma].
Reyners AK; Sprenger HG; Suurmeijer AJ; van der Graaf WT
Ned Tijdschr Geneeskd; 2006 Mar; 150(11):589-93. PubMed ID: 16610494
[TBL] [Abstract][Full Text] [Related]
40. Response of AIDS-associated Kaposi sarcoma to highly active antiretroviral therapy alone.
Paparizos VA; Kyriakis KP; Papastamopoulos V; Hadjivassiliou M; Stavrianeas NG
J Acquir Immune Defic Syndr; 2002 Jun; 30(2):257-8. PubMed ID: 12045689
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
